CA2064869A1 - Adenosine derivatives, their production and use - Google Patents

Adenosine derivatives, their production and use

Info

Publication number
CA2064869A1
CA2064869A1 CA002064869A CA2064869A CA2064869A1 CA 2064869 A1 CA2064869 A1 CA 2064869A1 CA 002064869 A CA002064869 A CA 002064869A CA 2064869 A CA2064869 A CA 2064869A CA 2064869 A1 CA2064869 A1 CA 2064869A1
Authority
CA
Canada
Prior art keywords
carbonate
ethylamide
desoxy
purinyl
beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002064869A
Other languages
English (en)
French (fr)
Inventor
Fulvio Gadient
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2064869A1 publication Critical patent/CA2064869A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CA002064869A 1990-08-16 1991-08-13 Adenosine derivatives, their production and use Abandoned CA2064869A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP4025879.3 1990-08-16
DE4025879A DE4025879A1 (de) 1990-08-16 1990-08-16 Neue adenosin derivate, deren herstellung und verwendung

Publications (1)

Publication Number Publication Date
CA2064869A1 true CA2064869A1 (en) 1992-02-17

Family

ID=6412310

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002064869A Abandoned CA2064869A1 (en) 1990-08-16 1991-08-13 Adenosine derivatives, their production and use

Country Status (11)

Country Link
EP (1) EP0496852A1 (de)
JP (1) JPH05502889A (de)
AU (1) AU638600B2 (de)
CA (1) CA2064869A1 (de)
CS (1) CS97892A3 (de)
DE (1) DE4025879A1 (de)
FI (1) FI921691A0 (de)
HU (1) HUT60504A (de)
PL (1) PL294368A1 (de)
TW (1) TW197448B (de)
WO (1) WO1992003463A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5165793A (en) * 1992-10-01 1994-04-26 Mcneilab, Inc. Derivatives of 7,8-disubstituted guanosines
GB9301000D0 (en) * 1993-01-20 1993-03-10 Glaxo Group Ltd Chemical compounds
CN114437159B (zh) * 2022-04-11 2022-06-28 佛山市晨康生物科技有限公司 一种环状碳酸酯核苷类化合物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4167565A (en) * 1976-11-08 1979-09-11 Abbott Laboratories Adenosine-5'-carboxamides and method of use
US4514405A (en) * 1981-09-17 1985-04-30 Merck Patent Gesellschaft Mit Beschrankter Haftung Use of adenosine derivatives as anticonvulsants
DE3406533A1 (de) * 1984-02-23 1985-08-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten
AU579412B2 (en) * 1984-10-26 1988-11-24 Warner-Lambert Company N` - substituted adenosines

Also Published As

Publication number Publication date
FI921691A0 (fi) 1992-04-15
CS97892A3 (en) 1992-08-12
PL294368A1 (en) 1993-06-28
EP0496852A1 (de) 1992-08-05
DE4025879A1 (de) 1992-02-20
WO1992003463A1 (de) 1992-03-05
AU638600B2 (en) 1993-07-01
HUT60504A (en) 1992-09-28
HU9201080D0 (en) 1992-06-29
AU8303291A (en) 1992-03-17
JPH05502889A (ja) 1993-05-20
TW197448B (de) 1993-01-01

Similar Documents

Publication Publication Date Title
US9351970B2 (en) Anti-viral pyrimidine nucleoside analogues
CA2147893C (en) Enantiomerically pure .beta.-d-dioxolane nucleosides with selective anti-hepatitis .beta. virus activity
NZ250414A (en) Substituted 5'-deoxy-5-fluorocytidines and pharmaceutical compositions
US5219840A (en) Antihypertensive 9-(2,N6 -disubstituted adenyl) ribofuranuronic acid derivatives
NO173653B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 6-benzoksazinyl- og 6-benzotiazinyl-2,3,4,5-tetrahydropyridazin-3-oner
GB2203149A (en) 1-(6-amino-9-purinyl)- beta -D-ribofuranuronic acid amides and thioamides
AU2002246956B2 (en) Inhibitors of ADP-ribosyl transferases, cyclases, and hydrolases, and uses thereof
EP3476854A1 (de) Nukleosid-cyclophosphat-verbindung als vorläufer eines antiviralen arznemittels und verwendung davon
US5534503A (en) 2'-O, N6 -disubstituted and 2'-O, N6, 2-trisubstituted adenosines and their medicinal uses
US4855288A (en) Furanuronic acid derivatives, process for their production and their use
CA2064869A1 (en) Adenosine derivatives, their production and use
EP0539442B1 (de) Enzyminaktivatoren
US4849423A (en) Purine derivatives, medicaments containing them and methods of treating cardiac insufficiencies and irregularities with them.
EP1265871B1 (de) Pyridazinyl phenyl hydrazone nützlich gegen kongestives herzversagen
NZ240719A (en) Adenosine-2',3'-carbonates, process for their preparation and use thereof.
IE914023A1 (en) New adenosine derivatives, their production and use
EP0831092B1 (de) Hydrochinon-Derivate und deren pharmazeutische Verwendung
US4980351A (en) 3-aminopropoxyaryl derivatives having cardiotonic and antihypertensive use and compositions thereof
US5179084A (en) Antiviral phosphoric acid esters of oxetanocins
SK146096A3 (en) Adenosine derivatives, processes for their preparation, their use for the preparation of drugs, their use in therapy and pharmaceutical compositions containing them
PT99600A (pt) Processo para a preparacao de novos derivados de adenosina e de composicoes farmaceuticas que os contem
IE54121B1 (en) Pharmaceutically active imidazolecarboxylic acid derivatives
RO110236B1 (ro) Derivați de adenozin-2’,3’-carbonati și procedeu de obținere a acestora
JPH0588709B2 (de)

Legal Events

Date Code Title Description
FZDE Dead